Insider trade

CEO sold ~$3.27M of ALHC shares in the open market

Traded Mar 10, 2026 · Filed Mar 11, 2026

Why it stands out

The CEO of Alignment Healthcare sold $3.27M of Alignment Healthcare shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEOIndirect holding$1M+Pre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$3,273,552

Shares × reported transaction price

Timing vs results

12 days after results of Feb 26, 2026, 51 days before results of Apr 30, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+1.0%	−2.2%	+3.2%
30 days	+13.8%	+0.5%	+13.4%
90 days	+6.6%	+9.0%	−2.4%
180 days	−25.3%	+13.3%	−38.5%

Past results only. Not a forecast.

Date of Rule 10b5-1 plan adoption: 03/12/2025
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.86 to $18.57. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Automatic saleFiled 6mo ago

Scheduled in advanceFiled 6mo ago

Scheduled in advanceFiled 6mo ago